SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides to buy Aspen’s Brazil unit for $75 m

05 Mar 2010 Evaluate

Pharma firm Strides Arcolab has entered into an agreement with South Africa-based Aspen to acquire the latter’s facility in Brazil for $75 million (nearly Rs 343 crore). In an effort to focus on injectable business, the company has entered into an understanding with Aspen to acquire its facility in Campos, Brazil with related products for $75 million.

 

The buying of Campos unit is part of a well-integrated strategy for Strides with licensing and supply agreement with global partners already in place. The facility manufactures penems and penicillins and penem is a key domain for Strides. The acquisition is subjected to regulatory approvals.

 

Penems and penicillins form an important part of Strides speciality injectable business and licensing agreement for penems have been concluded with various customers on a worldwide basis making the acquisition an important part of growing its speciality injectable business.

 

Aspen is Africa’s largest pharmaceutical manufacturer and a major supplier of healthcare and nutritional products. The group has a presence in Australia, India, Brazil, and the UK, and also exports to many other territories across the globe.

crackcrack

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×